Actavia Life Sciences, Inc.
RASP - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$385.91K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $385,906.00 |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-0.01 |
| Beta | -6.96 |
| Outstanding Shares | 771,811,360 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -0.06 |
|---|---|
| PEG | 0.07 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Actavia Life Sciences, Inc.
1 employees
CEO: Keeren Shah
Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating sma...